Für diesen Artikel ist leider kein Bild verfügbar.

Genetic Factors in Drug Therapy

Clinical and Molecular Pharmacogenetics
Buch | Hardcover
681 Seiten
1993
Cambridge University Press (Verlag)
978-0-521-41296-4 (ISBN)
159,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
This is the first comprehensive work of reference to survey in depth the wide-ranging variability in the response of individuals to drugs. This can be because of differences in biotransformation of drugs or because of differences in receptor responses. This variability in response has profound implications in terms of drug therapy, understanding mechanisms of drug metabolism and action, and in terms of understanding genetic polymorphism and its links with disease. New human genes have been discovered by studying these phenomena. Adverse reactions occur more commonly on standard drug dose regimens in some phenotypes. Similarly, the responses of disorders to standard treatments are affected by genetic constitution. Additionally, the possession of some pharmacogenetic phenotypes renders some individuals more prone to develop spontaneous disorders. This field is being revolutionised by advances in molecular genetics and this book provides a reference on which to base new advances.

Preface; Part I. Introduction: 1. The arrangement of the information in this volume; 2. General introduction; 3. Classification of pharmacogenetic phenomena; Part II. Cytochrome P450 Based Phenomen: 4. Cytochrome P450 - general features; 5. Artlhydrocarbon hydroxylase (cytochrome P450 1A1 and 1A2); 6. The mephenytoin hydroxylation polymorphism (cytochrome P450 2C18); 7. The debrisoquine/sparteine polymorphism (cytochrome P450 2D6); 8. The cytochrome P450 3A subfamily; 9. Tolbutamide; 10. Phenytoin; 11. Some other drugs of special interest; 12. Cytochrome P450 reductase; 13. General conclusions; Part III. Cholinesterase: 14. Cholinesterase; Part IV. Alcohol and Alcoholism: 15. Alcohol and alcoholism; Part V. N-Acetyltransferase: 16. N-Acetyltransferase; Part VI. Miscellaneous Phase II Reactions Showing Genetic Variability in Drug Metabolism: 17. The glucosidation of amobarbital; 18. Glucuronosyltransferases; 19. Glutathione-S-transferase; 20. Methylation reactions; 21. Paraoxonase; 22. Sulphotransferases; 23. Sulphoxidation deficiency; 24. Halothane hepatitis and other topics; Part VII. Glucose-6-Phosphate Dehydrogenase Deficiency: 25. Glucose-6-phosphate dehydrogemase deficiency; Part VIII. The Hepatic Porphyrias: 26. The hepatic porphyrias; Part IX. Malignant Hyperthermia: 27. Malignant hyperthermia; Part X. Miscellaneous Systems Showing Genetic Variability in Response to Drugs; 28. Chlorpropamide-alcohol flushing; 29. Glucocorticosteroids and intraocular pressure; 30. Unstable haemoglobins; 31. Human lymphocyte antigens and adverse reactions to drugs; 32. The polymorphism for tasting phenylthiocarbamide (PTC syn phenylthiourea); 33. Hereditary anticoagulant resistance; 34. NADH-cytochrome b5 reductase; 35. Catalase; 36. Antibiotic-induced deafness, chloramphenicol toxicity and other topics; Part XI. Polygenic Effects in Pharmacogenetics: 37. Polygenic effects in pharmacogenetics; Part XII. Common Themes: 38. Common themes; Part XIII. Conclusions: 39. Conclusions; Part XIV. Appendices: Index.

Erscheint lt. Verlag 16.12.1993
Zusatzinfo 181 Tables, unspecified; 8 Halftones, unspecified; 199 Line drawings, unspecified
Verlagsort Cambridge
Sprache englisch
Maße 210 x 263 mm
Gewicht 1894 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Studium 2. Studienabschnitt (Klinik) Humangenetik
ISBN-10 0-521-41296-X / 052141296X
ISBN-13 978-0-521-41296-4 / 9780521412964
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
21,99
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
16,00